Menu

• Ask a Health Expert about BLOOD CREATINE DECREASED
• Post Your Side Effect related to BLOOD CREATINE DECREASED
• BLOOD CREATINE DECREASED and FDA Warnings
• BLOOD CREATINE DECREASED in Patients Wiki
• Report BLOOD CREATINE DECREASED in Drug Side Effect Survey

BLOOD CREATINE DECREASED side effect

What is BLOOD CREATINE DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prograf Side Effects Report #5528290-2
Health Professional from FRANCE reported PROGRAF problem on Nov 05, 2007. Female patient, 49 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, blood immunoglobulin g increased, bone marrow failure, mucosal inflammation, pancytopenia, purpura, pyrexia, thrombocytopenia, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with ROVALCYTE, PANTOPRAZOLE, DELURSAN. Patient was hospitalized. Patient recovered.

Seroquel Side Effects Report #5456194-2
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2006. Female patient, 28 years of age, weighting 145.1 lb, was diagnosed with bipolar i disorder and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, . SEROQUEL dosage: unknown. Patient recovered.

Byetta Side Effects Report #5425036-3
Consumer or non-health professional from UNITED STATES reported BYETTA problem on June 12, 2007. Female patient, 76 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, cystitis, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE, LISINOPRIL, GLIPIZIDE. Patient recovered.

Byetta Side Effects Report #5425036-3
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, 76 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, cystitis, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE, LISINOPRIL, GLIPIZIDE. Patient recovered.


Revlimid Side Effects Report #5284269-X
Physician from UNITED STATES reported REVLIMID problem on Mar 15, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, . REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5519611-5
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 05, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: abasia, basophil percentage increased, blood creatine decreased, blood urea decreased, cardiac failure congestive, cholesterol granuloma, depression, mean cell haemoglobin increased, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with BIRTH CONTROL S, EFFEXOR, AMBIEN, HYDROCODONE W, ZANAFLEX, PROVIGIL, LASIX, VITAMIN E. Patient died on 10/11/2007.

Tarceva Side Effects Report #5492786-2
Physician from GERMANY reported TARCEVA problem on Oct 04, 2007. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, angiopathy, blood creatine decreased, blood glucose increased, blood lactate dehydrogenase increased, bronchial neoplasm, bronchostenosis, c-reactive protein increased, cerebral infarction, . TARCEVA dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, RAMIPRIL COMP, HYDROCHLOROTHIAZIDE, ESOMEPRAZOLE, ACETYLCYSTEINE, DEXAMETHASONE, PROMETHAZINE. Patient was hospitalized. Patient recovered.